Deepti Chittamuru1, Victoria Frye2, Beryl A Koblin3, Bridgette Brawner3, Hong-Van Tieu4, Annet Davis3, Anne Teitelman3. 1. Department of Public Health, School of Social Sciences, Humanities and Arts, University of California Merced, Merced, CA. 2. Department of Community Health and Social Medicine, City University of New York School of Medicine, New York, NY. 3. School of Nursing, University of Pennsylvania, Philadelphia, PA. 4. Laboratory of Infectious Disease Prevention, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY.
Abstract
BACKGROUND: Stigma is an important contributor to the continued HIV epidemic in the United States (US). In 2016, women made up nearly one in five of all new infections. Pre-exposure HIV Prophylaxis or PrEP is a medication that can be taken to prevent HIV acquisition; however, PrEP is significantly underutilized by women at risk for infection. How PrEP stigma relates to PrEP initiation among women is not well understood. METHODS: Surveys were completed by 160 PrEP-eligible women aged 18-55 in Philadelphia, PA and New York City, NY. Associations between PrEP stigma, HIV stigma, and PrEP initiation intention were modeled using multinomial logistic regression, controlling for sociodemographic and theoretically-relevant variables. RESULTS: Participants ranged in age from 18 to 55 years (M = 40.2; SD = 11.78). Most (79%) identified as Black or African-American and/or Latina and 36% had completed high-school or less. Higher PrEP stigma was significantly associated with lower PrEP initiation intention, while controlling for other theoretically-relevant and sociodemographic variables. HIV stigma was not related to PrEP initiation intention. CONCLUSIONS: HIV prevention interventions seeking to increase PrEP initiation among PrEP-eligible, urban women need to address the role that PrEP stigma plays in PrEP uptake.
BACKGROUND: Stigma is an important contributor to the continued HIV epidemic in the United States (US). In 2016, women made up nearly one in five of all new infections. Pre-exposure HIV Prophylaxis or PrEP is a medication that can be taken to prevent HIV acquisition; however, PrEP is significantly underutilized by women at risk for infection. How PrEP stigma relates to PrEP initiation among women is not well understood. METHODS: Surveys were completed by 160 PrEP-eligible women aged 18-55 in Philadelphia, PA and New York City, NY. Associations between PrEP stigma, HIV stigma, and PrEP initiation intention were modeled using multinomial logistic regression, controlling for sociodemographic and theoretically-relevant variables. RESULTS: Participants ranged in age from 18 to 55 years (M = 40.2; SD = 11.78). Most (79%) identified as Black or African-American and/or Latina and 36% had completed high-school or less. Higher PrEP stigma was significantly associated with lower PrEP initiation intention, while controlling for other theoretically-relevant and sociodemographic variables. HIV stigma was not related to PrEP initiation intention. CONCLUSIONS: HIV prevention interventions seeking to increase PrEP initiation among PrEP-eligible, urban women need to address the role that PrEP stigma plays in PrEP uptake.
Authors: Beryl A Koblin; DaShawn Usher; Vijay Nandi; Hong-Van Tieu; Eddie Bravo; Debbie Lucy; London Miles; Geneva Ortiz; Marcia J Kindlon; Donna M Parisi; Victoria Frye Journal: AIDS Behav Date: 2018-08
Authors: Bulent Turan; Abigail M Hatcher; Sheri D Weiser; Mallory O Johnson; Whitney S Rice; Janet M Turan Journal: Am J Public Health Date: 2017-04-20 Impact factor: 9.308
Authors: Sarit A Golub; Kristi E Gamarel; H Jonathon Rendina; Anthony Surace; Corina L Lelutiu-Weinberger Journal: AIDS Patient Care STDS Date: 2013-04 Impact factor: 5.078
Authors: Ingrid T Katz; Annemarie E Ryu; Afiachukwu G Onuegbu; Christina Psaros; Sheri D Weiser; David R Bangsberg; Alexander C Tsai Journal: J Int AIDS Soc Date: 2013-11-13 Impact factor: 5.396
Authors: R J Munthali; A L Stangl; D Baron; I Barré; S Harvey; L Ramskin; M Colombini; N Naicker; S Kapiga; S Delany-Moretlwe Journal: AIDS Behav Date: 2022-07-01
Authors: Rachel K Scott; Shawnika J Hull; Jim C Huang; Megan Coleman; Peggy Ye; Pam Lotke; Jason Beverley; Patricia Moriarty; Dhikshitha Balaji; Allison Ward; Jennifer Holiday; Ashley R Brant; Martha Cameron; Rick Elion; Adam Visconti Journal: Arch Sex Behav Date: 2022-05-27
Authors: Sarita Sonalkar; William R Short; Arden McAllister; Corinne Kete; Leah Ingeno; Jessica Fishman; Helen C Koenig; Courtney A Schreiber; Anne M Teitelman Journal: Womens Health Issues Date: 2022-01-05
Authors: Gabriella Y Jackson; Caroline K Darlington; Hong Van Tieu; Bridgette M Brawner; Dalmacio D Flores; Jacqueline A Bannon; Annet Davis; Victoria Frye; Deepti Chittamuru; Paige Gugerty; Beryl A Koblin; Anne M Teitelman Journal: Cult Health Sex Date: 2021-02-04
Authors: Anne M Teitelman; Hong-Van Tieu; Dalmacio Flores; Jacqueline Bannon; Bridgette M Brawner; Annet Davis; Paige Gugerty; Beryl Koblin Journal: AIDS Care Date: 2021-03-09
Authors: Rasheeta Chandler; Dominique Guillaume; Jessica Wells; Natalie Hernandez Journal: Int J Environ Res Public Health Date: 2022-01-27 Impact factor: 3.390